Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 950-955, February 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reibnegger, G. J.
Right arrow Articles by Wachter, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reibnegger, G. J.
Right arrow Articles by Wachter, H.

Neopterin as a Prognostic Indicator in Patients with Carcinoma of the Uterine Cervix1

Gilbert J. Reibnegger, Alfred H. Bichler, Otto Dapunt, Dietmar N. Fuchs, Lothar C. Fuith, Arno Hausen, Heinz M. Hetzel, Hermann Lutz2, Ernst R. Werner and Helmut Wachter3

Institute for Medical Chemistry and Biochemistry [G. J. R., D. N. F., A. H., H. L., E. R. W., H. W.], and Department of Obstetrics and Gynecology [A. H. B., O. D., L. C. F., H. M. H.], University of Innsbruck, Innsbruck, Austria

In vitro, neopterin, a pyrazinopyrimidine compound, is excreted by human monocytes-macrophages after induction by supernatants from activated T-lymphocytes or by recombinant {gamma}-interferon. In vivo, it represents a noninvasive test for activation of cellular immune reactions. To evaluate the prognostic value of pretherapeutic urinary neopterin levels and of serial neopterin measurements during follow-up in women with cervical cancer, 1088 urine specimens from 186 consecutive patients were analyzed. Clinical assessments were made without knowledge of the results of neopterin assays (a "blinded" assessment). During the observation period (June 1980 to March 1984), 27 relapses, 18 metastases, and 26 deaths were seen. The prognostic significance of pretherapeutic neopterin and other possible prognostic clinical and laboratory parameters was tested by the univariate and multivariate Cox proportional hazards model using a stratification according to stage and surgical treatment. The combination of age at diagnosis, pretherapeutical hemoglobin, leukocyte count, and neopterin was found to predict survival best. On the basis of this result, risk groups were identified exhibiting markedly different survival behavior. A highly significant association was found between serial neopterin measurements and the risk for a relapse, metastasis, or death. The data suggest that urinary neopterin levels might be a useful adjuvant parameter in monitoring women with cervical cancer.

1 Supported by the Austrian research funds "Zur Förderung der wissenschaftlichen Forschung," Project No. 4905.

2 Recipient of a postdoctoral research fellowship from the Deutsche Forschungsgemeinschaft.

3 To whom requests for reprints should be addressed, at Institut für Medizinische Chemie, Der Universität Innsbruck, Fritz Pregl-Str. 3, A-6020 Innsbruck, Austria.

Received 5/29/85. Revised 8/22/85. Revised 10/24/85. Accepted 10/25/85.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
R. Prommegger, B. Widner, C. Murr, A. Unger, D. Fuchs, and G. M. Salzer
Neopterin: a prognostic variable in operations for lung cancer
Ann. Thorac. Surg., December 1, 2000; 70(6): 1861 - 1864.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.